Real-world results confirm the benefits of dosing ZOMETA^® every 3 to 4 weeks in patients like Anthony¹⁵

Using alternative dosing schedules significantly compromises the benefits of ZOMETA¹⁵

Rate of SREs by dosing regimen^15*

*There are limitations to the study because the results are from a retrospective claims
database analysis.

Treatment with ZOMETA 4 mg every 3 to 4 weeks significantly reduced the rate of skeletal morbidity (measured as number of events per month) vs no treatment¹⁵
No other dosing schedule is proven to protect patients from SREs^2,12-14

ZOMETA is proven in clinical trials to delay and reduce SREs in lung cancer and other solid tumours through 21 months²

Achieve maximum potential benefit—treat with ZOMETA 4 mg every 3 to 4 weeks

Page

1 2 3

Disclaimer: This is an international website for ZOMETA^® (zoledronic acid) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the US Residents link at the top of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.

Real-world results confirm the benefits of dosing ZOMETA® every 3 to 4 weeks in patients like Anthony15

ZOMETA is proven in clinical trials to delay and reduce SREs in lung cancer and other solid tumours through 21 months2

Achieve maximum potential benefit—treat with ZOMETA 4 mg every 3 to 4 weeks

Real-world results confirm the benefits of dosing ZOMETA^® every 3 to 4 weeks in patients like Anthony¹⁵

ZOMETA is proven in clinical trials to delay and reduce SREs in lung cancer and other solid tumours through 21 months²